Medifast Inc (MED) stock

MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3064% below fair value

$12.97+0.11 (+0.86%)

Close on Nov 13, 2026Market cap $145.04MP/E –Yield 0.00%

Medifast statistics

90 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 16, 2027 (estimated, during market hours)
Last ex-dividend date: Sep 18, 2023
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $145.04M; $1.17B
Enterprise Value: -$27.20M; $1.62B
PS Ratio: 0.48; 0.80
PB Ratio: 0.80; 1.83
P/TBV Ratio: 0.80; 3.48

Enterprise valuationIndustry

EV / Sales: -0.09; 1.02

Share statisticsIndustry

Shares Outstanding: 11M; 67M
Shares Change (YoY): 0.78%; 0.58%
Shares Change (QoQ): 0.02%; 0.00%
Float: 10M; 46M
Shares Held by Insiders: 12.3%; 10.2%
Shares Held by Institutions: 73.9%; 57.3%

Short sellingIndustry

Short Interest: 1M; –
Short Interest Change: 12.1%; 1.45%
Short % of Float: 13.2%; 6.50%
Short % of Shares Outstanding: 11.6%; 4.93%
Days to Cover: 8.24; 4.50

Stock price statisticsIndustry

52-Week High: $13.63; –
52-Week Low: $9.22; –
20-Day Moving Average: $12.53; –
50-Day Moving Average: $12.13; –
200-Day Moving Average: $11.38; –
Average True Range (14): $0.44; –
Price Change (1 Week): 1.25%; 0.59%
Price Change (1 Month): 7.55%; 1.37%
Price Change (3 Months): 13.4%; -4.99%
Price Change (6 Months): 3.93%; -5.78%
Price Change (YTD): 21.4%; -14.3%
Price Change (1 Year): 11.5%; -12.5%
Price Change (3 Years): -80.5%; -32.3%
Price Change (5 Years): -94.3%; -40.7%
Price Change (10 Years): -66.8%; -5.51%
Average Volume (10 Days): 108,401; –
Average Volume (20 Days): 136,068; –
Average Volume (90 Days): 143,454; –
Relative Volume: 0.47; 0.71
Relative Strength Index (14): 58.6; 49.9
Volatility (1 Year): 53.7%; 46.1%
Beta (5 Years): 0.71; 0.46

MarginsIndustry

Gross Margin: 69.2%; 29.4%
Operating Margin: -11.6%; 3.49%
Pretax Margin: -9.73%; 4.13%
Profit Margin: -13.6%; 1.49%
EBITDA Margin: -7.35%; 5.70%
FCF Margin: -1.29%; 6.10%

Returns on capitalIndustry

Return on Equity (ROE): -20.7%; 5.06%
Return on Assets (ROA): -16.1%; 1.47%
Return on Invested Capital (ROIC): -110.1%; 4.43%
Return on Capital Employed (ROCE): -17.6%; 5.34%

Financial positionIndustry

Current Ratio: 4.82; 1.39
Quick Ratio: 4.11; 0.56

GrowthIndustry

Revenue Growth (YoY): -30.3%; 2.72%
Net Income Growth (YoY): -16572.6%; -12.4%
EPS Growth (YoY): -37000.0%; -12.0%
FCF Growth (YoY): -698.9%; -0.54%
Revenue Growth (3Y CAGR): -37.7%; 1.93%
Revenue Growth (5Y CAGR): -16.2%; 6.06%

EfficiencyIndustry

Asset Turnover: 1.18; 0.91
Inventory Turnover: 4.15; 5.29
Revenue Per Employee: $788.35K; $664.16K
Profits Per Employee: -$107.51K; $16.51K
Employee Count: 380; 600
WACC: 8.65%; 7.48%

Income statement (TTM)Industry

Revenue: $299.57M; $814.99M
Gross Profit: $207.33M; $207.33M
Operating Income: -$34.78M; $423.10K
Pretax Income: -$29.15M; $11.82M
Net Income: -$40.85M; $2.26M
EBITDA: -$22.03M; $9.84M
EPS (Diluted): -$3.69; $0.14

Balance sheetIndustry

Cash & Short-Term Investments: $172.24M; $41.10M
Net Cash (Debt): $172.24M; -$512.30K
Net Cash Per Share: $15.40; -$0.04
Equity (Book Value): $180.28M; $143.59M
Book Value Per Share: $16.12; $5.66
Tangible Book Value: $180.28M; $4.47M
Working Capital: $160.06M; $25.54M

Cash flow (TTM)Industry

Operating Cash Flow: -$26.00K; $15.26M
Capital Expenditures: -$3.84M; -$60.19M
Free Cash Flow: -$3.87M; $99.47M
FCF Per Share: -$0.35; $1.40

Dividends and yieldsIndustry

Earnings Yield: -28.2%; 2.59%
FCF Yield: -2.67%; 4.77%
Dividend Yield: 0.00%; 3.56%
Shareholder Yield: 0.00%; 3.36%
Dividend Per Share: $0.00; $1.56
Years of Dividend Growth: 0; 4

Taxes and interestIndustry

Income Tax: $11.70M; $11.70M

Scores and fair valueIndustry

Altman Z-Score: 3.83; 2.54
Piotroski F-Score: 4; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	MED	S&P 500	Difference	MED per year	S&P 500 per year
1 month	+11.1%	-3.0%	+14.2 pts
3 months	+13.0%	-2.8%	+15.8 pts
Year to date	+21.4%	+11.5%	+10.0 pts
1 year	+13.2%	+13.5%	−0.3 pts
3 years	-79.1%	+77.7%	−156.8 pts	-40.7%	+21.1%
5 years	-93.6%	+72.6%	−166.2 pts	-42.3%	+11.5%
10 years	-57.2%	+308.2%	−365.3 pts	-8.1%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M MED shares were sold short on Oct 30, 2026, up 12.1% from the previous report, or 13.23% of the shares available to trade. At recent volumes it would take 8.2 days to buy them back. Over the last 20 sessions, 46.7% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	1,297,237	+12.1%	157,408	8.2
Oct 15, 2026	1,157,639	+9.9%	101,894	11.4
Sep 30, 2026	1,053,225	-43.4%	144,284	7.3
Sep 15, 2026	1,862,070	-1.1%	93,002	20.0
Aug 31, 2026	1,882,921	+3.2%	124,599	15.1
Aug 14, 2026	1,824,259	+22.9%	245,780	7.4
Jul 31, 2026	1,484,483	-9.5%	162,017	9.2
Jul 15, 2026	1,639,608	+5.0%	174,167	9.4
Jun 30, 2026	1,561,657	-27.6%	423,124	3.7
Jun 15, 2026	2,155,853	-0.9%	140,556	15.3
May 29, 2026	2,175,625	-0.5%	214,199	10.2
May 15, 2026	2,186,673	+7.6%	234,277	9.3